Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Clot Management Devices Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The market size for clot management devices has experienced strong growth in recent years. It will grow from $1.82 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 6.0%. Historically, this expansion has been driven by a rising incidence of deep vein thrombosis and pulmonary embolism, an increasing prevalence of cardiovascular diseases, the growth in interventional radiology procedures, expanding hospital vascular care capabilities, and improved awareness of clot-related complications.
The clot management devices market is anticipated to show robust expansion in the coming years. It is projected to increase to $2.37 billion in 2030, achieving a compound annual growth rate (CAGR) of 5.3%. This growth during the forecast period can be attributed to an aging population facing higher thrombotic risks, a rising need for minimally invasive vascular interventions, increased attention on early detection and treatment of clotting disorders, the establishment of more advanced stroke and thrombosis centers, and the growing adoption of endovascular treatment approaches. Significant trends expected during the forecast period include the increasing uptake of minimally invasive procedures for clot removal, a rise in the use of mechanical and aspiration thrombectomy devices, a heightened focus on rapid intervention for acute thrombotic events, the expansion of catheter-based treatments for DVT and PE, and a growing preference for retrievable inferior vena cava filters.
Get A Free Sample Report With In-Depth Market Insights:
Clot Management Devices Market Industry Drivers: What’s Behind The Revenue Growth?
The expanding need for hospital services is projected to drive the growth of the clot management device market in the future. Hospitals are healthcare institutions dedicated to offering medical treatment, care, and various services to people with illnesses, injuries, or other medical issues. The rise in hospitals can be attributed to several factors, including an aging demographic, urban development, improved access to healthcare, population growth, and the rise of medical tourism. Within healthcare, clot management devices play a crucial role in addressing conditions like deep vein thrombosis, pulmonary embolism, and ischemic strokes, offering patients efficient and less invasive treatment options while improving overall results and patient safety. For example, data from the American Health Care Association, a US-based nonprofit, indicated that by May 2024, the count of hospitals in the US had grown to 6,120, up from 5,129 in 2022. Consequently, the heightened need for hospitals is stimulating the expansion of the clot management device market.
Clot Management Devices Market Segment Outlook: Which Categories Are Growing Fastest?
The clot management devices market covered in this report is segmented –
1) By Product Type: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) devices, Inferior vena cava filters (IVCF)
2) By Percutaneous Thrombectomy Devices Type Outlook: Aspiration Thrombectomy Devices, Percutaneous Mechanical Thrombectomy Device
3) By End User: Diagnostic centers, Hospitals
Subsegments:
1) By Neurovascular Embolectomy Devices: Aspiration Embolectomy Devices, Mechanical Embolectomy Devices, Embolectomy Balloon Catheters
2) By Embolectomy Balloon Catheters: High-Pressure Balloon Catheters, Low-Pressure Balloon Catheters
3) By Percutaneous Thrombectomy Devices: Rotational Thrombectomy Devices, Aspiration Thrombectomy Devices
4) By Catheter-Directed Thrombolysis (CDT) Devices: Infusion Catheters, Guidewires For CDT
5) By Inferior Vena Cava Filters (IVCF): Permanent IVC Filters, Retrievable IVC Filters
#Clot Management Devices Market Growth Trends: What’s Shaping The Future Outlook?
Major companies operating in the clot management device market are developing innovative technologies, such as computer-assisted vacuum thrombectomy (CAVT) systems, to offer advanced features to customers. Computer-assisted vacuum thrombectomy (CAVT) systems are medical devices employed in the treatment of blood clots, particularly for conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE). For instance, in April 2024, Penumbra Inc., a US-based medical company, introduced the Lightning Flash 2.0. This is the latest clot aspiration and vacuum thrombectomy (CAVT) technology designed for rapid blood clot removal. The Lightning Flash 2.0 marks a significant advancement in clot management devices, providing improved performance and efficiency. This state-of-the-art device integrates cutting-edge AI and sophisticated engineering to enhance patient outcomes in both acute and chronic care settings. It includes advanced imaging and suction capabilities, facilitating precise and effective clot removal to meet the demands of various medical environments.
Clot Management Devices Market Competitive Overview And Top Companies
Major companies operating in the clot management devices market are Bayer AG, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Acandis GmbH & Co KG, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., MicroVention Inc., Inari Medical Inc., AngioDynamics Inc., Argon Medical Devices Inc., LeMaitre Vascular Inc., iVascular SLU, Straub Medical AG, Rapid Medical, C.R. Bard Inc., InspireMD Inc.
View The Full Clot Management Devices Market Report:
Clot Management Devices Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the clot management devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clot management devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
